Molecular Devices (NASDAQ:MDCC)
Historical Stock Chart
From Jul 2019 to Jul 2024
Molecular Devices Announces Webcast of Presentation at Thomas
Weisel Partners Growth Forum 7.0
SUNNYVALE, Calif., June 8 /PRNewswire-FirstCall/ -- Molecular Devices
Corporation (NASDAQ:MDCC), a leader in innovative solutions for drug discovery
and life sciences research, today announced that Joseph D. Keegan, Ph.D., CEO
and President, will present at the Thomas Weisel Partners Growth Forum 7.0 on
Tuesday, June 14, 2005 at 9:45 a.m. (PDT) at the Four Seasons Hotel in San
Francisco.
Molecular Devices' audio presentation will be webcast live, and can be accessed
at: http://www.veracast.com/webcasts/twp/GF2005/71204478.cfm or on the
investor page at the Company's website http://www.moleculardevices.com/.
The presentation will be archived on the Company's website for 5 days.
Molecular Devices Corporation is a leading supplier of high-performance
bioanalytical measurement systems that accelerate and improve drug discovery
and other life sciences research. The Company's systems and consumables enable
pharmaceutical and biotechnology companies to leverage advances in genomics,
proteomics and parallel chemistry to facilitate the high-throughput and
cost-effective identification and evaluation of drug candidates. The Company's
solutions are based on its advanced core technologies that integrate its
expertise in engineering, molecular and cell biology and chemistry. Molecular
Devices enables its customers to improve research productivity and
effectiveness, which ultimately accelerates the complex process of discovering
and developing new drugs.
DATASOURCE: Molecular Devices Corporation
CONTACT: Tim Harkness of Molecular Devices Corporation, +1-408-747-3533
Web site: http://www.moleculardevices.com/